Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late

British Journal of Dermatology

Volumn 150, Issue 5, 2004, Pages 852-859

  Vissers, W H P M ^a   Arndtz, C H M ^a   Muys, L ^a   Van Erp, P E J ^a   De Jong, E M G ^a   Van De Kerkhof, P C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytotoxic T cells; Memory effector T cells; Natural killer T cells; Spreading psoriasis

Indexed keywords

CD2 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; CELL RECEPTOR; INTERLEUKIN 2 RECEPTOR; KI 67 ANTIGEN; IMMUNOGLOBULIN RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EPIDERMIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINIZATION; MEMORY CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PSORIASIS VULGARIS; SKIN BIOPSY; STATISTICAL SIGNIFICANCE; DISEASE COURSE; HELPER CELL; IMAGE PROCESSING; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KERATINOCYTE; METABOLISM; PATHOLOGY; PSORIASIS; SKIN; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD45; DISEASE PROGRESSION; EPIDERMIS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOLOGIC MEMORY; KERATINOCYTES; KI-67 ANTIGEN; KILLER CELLS, NATURAL; PSORIASIS; RECEPTORS, IMMUNOLOGIC; SKIN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 3042697256     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.05863.x     Document Type: Article

References (26)

1. Gerritsen MJ, Elbers ME, De Jong EM et al. Recruitment of cycling epidermal cells and expression of filaggrin, involucrin and tenascin in the margin of the active psoriatic plaque, in the uninvolved skin of psoriatic patients and in the normal healthy skin. J Dermatol Sci 1997; 14: 179-88.
2. Mommers JM, Rossum MM, Erp PE et al. Changes in keratin 6 and keratin 10 (co-)expression in lesional and symptomless skin of spreading psoriasis. Dermatology 2000; 201: 15-20.
3. Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 2002; 46: 1-23.
4. Van de Kerkhof PC, Rulo HF, van Pelt JP et al. Expression of endoglin in the transition between psoriatic uninvolved and involved skin. Acta Derm Venereol 1998; 78: 19-21.
5. van Pelt JP, Kuijpers SH, van de Kerkhof PC et al. The CD11b/CD18-integrin in the pathogenesis of psoriasis. J Dermatol Sci 1998; 16: 135-43.
6. van Ruissen F, de Jongh GJ, Zeeuwen PL et al. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures. J Cell Physiol 1996; 168: 442-52.
7. Chen Q, Ma Y, Ross AC. Opposing cytokine-specific effects of all trans-retinoic acid on the activation and expression of signal transducer and activator of transcription (STAT)-1 in THP-1 cells. Immunology 2002; 107: 199-208.
8. Chen G, McCormick TS, Hammerberg C et al. Basal keratinocytes from uninvolved psoriatic skin exhibit accelerated spreading and focal adhesion kinase responsiveness to fibronectin. J Invest Dermatol 2001; 117: 1538-45.
9. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J Clin Invest 1995; 95: 317-27.
10. de Jong EMGJ, Schalkwijk J, van de Kerkhof PCM. Epidermal proliferation and differentiation, composition of the inflammatory infiltrate and the extracellular matrix in the margin of the spreading psoriatic lesion. Eur J Dermatol 1991; 1: 221-7.
11. Placek W, Haftek M, Thivolet J. Sequence of changes in psoriatic epidermis. Immunocompetent cell redistribution precedes altered expression of keratinocyte differentiation markers. Acta Derm Venereol 1988; 68: 369-77.
12. Owen CM, Harrison PV. Successful treatment of severe psoriasis with basiliximab, an interleukin-2 receptor monoclonal antibody. Clin Exp Dermatol 2000; 25: 195-7.
13. Mrowietz U. Treatment targeted to cell surface epitopes. Clin Exp Dermatol 2002; 27: 591-6.
14. Ellis CN, Krueger GG. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. N Engl J Med 2001; 345: 248-55.
15. Austin LM, Ozawa M, Kikuchi T et al. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alfa, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients. J Invest Dermatol 1999; 113: 752-9.
16. Ghoreschi K, Thomas P, Breit S et al. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat Med 2003; 9: 40-6.
17. Cameron AL, Kirby B, Fei W et al. Natural killer and natural killer-T cells in psoriasis. Arch Dermatol Res 2002; 294: 363-9.
18. Lanier LL. NK cell receptors. Annu Rev Immunol 1998; 16: 359-93.
19. Lopez-Botet M, Bellon T, Llano M et al. Paired inhibitory and triggering NK cell receptors for HLA class I molecules. Hum Immunol 2000; 61: 7-17.
20. Nickoloff BJ. Skin innate immune system in psoriasis: friend or foe? J Clin Invest 1999; 104: 1161-4.
21. Mommers JM, Rossum MM, Hooijdonk CA et al. Quantification of epidermal cell populations in the centre and margin of stable psoriatic plaques. Arch Dermatol Res 1999; 291: 88-92.
22. Chang JC, Smith LR, Froning KJ et al. CD8+ T-cells in psoriatic lesions preferentially use T-cell receptors V beta 3 and/or V beta 13.1 genes. Ann NY Acad Sci 1995; 756: 370-81.
23. Bonish B, Jullien D, Dutronc Y et al. Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK/T cells. J Immunol 2000; 165: 4076-85.
24. Mieza MA, Itoh T, Cui JQ et al. Selective reduction of V alpha 14+ NK T cells associated with disease development in autoimmune-prone mice. J Immunol 1996; 156: 4035-40.
25. Koreck A, Suranyi A, Szony BJ et al. CD3+CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis. Clin Exp Immunol 2002; 127: 176-82.
26. Aractingi S, Briand N, Le Danff C et al. HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol 2001; 159: 71-7.